Keywords: Altoprev; Antara; Bezalip; Colestid; Crestor; Epanova; Ezetrol; Fenoglide; Fibricor; Flolipid; Juxtapid; Kynamro; Lescol; Lipidil; Lipitor; Lipofen; Livalo; Lodalis; Lopid; Niacor; Niaspan; Olestyr; PCSK9 inhibitors; Praluent; Pravachol; Prevalite; Questran; Repatha; Slo-Niacin; Tricor; Triglide; Trilipix; Vascepa; Vytorin; Welchol; Zetia; Zocor; Zypitamag; adverse effects; alirocumab; atorvastatin; bezafibrate; bile acid sequestrants; cholesterol; cholesterol absorption inhibitor; cholestyramine; colesevelam; colestipol; dosage; drug interactions; efficacy; evolucumab; ezetimibe; ezetimibe/simvastatin; fenofibrate; fenofibric acid; fish oil; fluvastatin; gemfibrozil; hypercholesterolemia; hypertriglyceridemia; icosapent ethyl; lomitapide; lovastatin; mipomersen; niacin; omega-3 fatty acids; pitavastatin; pravastatin; pregnancy; rosuvastatin; safety; simvastatin; statins.